Washington Trust Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
2,711
+44
| +2% | +$17.8K | 0.09% | 96 |
|
|
2025
Q1 | $1.33M | Sell |
2,667
-1,721
| -39% | -$856K | 0.12% | 85 |
|
|
2024
Q4 | $2.28M | Buy |
4,388
+3,102
| +241% | +$1.61M | 0.19% | 70 |
|
|
2024
Q3 | $795K | Buy |
1,286
+76
| +6% | +$47K | 0.07% | 107 |
|
|
2024
Q2 | $669K | Buy |
1,210
+113
| +10% | +$62.5K | 0.06% | 112 |
|
|
2024
Q1 | $637K | Sell |
1,097
-44
| -4% | -$25.6K | 0.06% | 111 |
|
|
2023
Q4 | $606K | Sell |
1,141
-76
| -6% | -$40.3K | 0.06% | 114 |
|
|
2023
Q3 | $616K | Buy |
1,217
+123
| +11% | +$62.3K | 0.06% | 114 |
|
|
2023
Q2 | $571K | Buy |
1,094
+9
| +0.8% | +$4.7K | 0.06% | 117 |
|
|
2023
Q1 | $625K | Sell |
1,085
-12
| -1% | -$6.92K | 0.06% | 115 |
|
|
2022
Q4 | $604K | Sell |
1,097
-173
| -14% | -$95.3K | 0.07% | 115 |
|
|
2022
Q3 | $644K | Buy |
1,270
+61
| +5% | +$30.9K | 0.06% | 122 |
|
|
2022
Q2 | $657K | Sell |
1,209
-3,164
| -72% | -$1.72M | 0.06% | 120 |
|
|
2022
Q1 | $2.58M | Sell |
4,373
-105
| -2% | -$62K | 0.18% | 82 |
|
|
2021
Q4 | $2.99M | Buy |
+4,478
| New | +$2.99M | 0.2% | 78 |
|